In the present work, an attempt has been made to develop immediate release coated tablets of Ritonavir by hot met extrusion method using 16 station rotary tablet punching machine. The blend of all the formulations showed good flow properties such as bulk density, tapped density. The prepared IR coated tablets of ritonavir shown good post compression parameters. They passed all the quality control evalu ation parameters as per USP limits. Among all the formulations, F5 formulation showed maximum % drug release i.e., 99 % in 120 mins hence it is considered as optimized formulation. The optimized formulation was compared to innovator tablets.
INTRODUCTION

Tablets
Tablets are defined as solid pharmaceutical dosage forms containing drug substances with or without suitable diluents and prepared either by compression or molding methods. Tablets remain popular as a dosage form because of the advantages, afforded both to the manufacturer (simplicity & economy of preparation, stability and convenience in packing, shipping and dispensing). Although tablets are more frequently discoid in shape, they also may be round, oval, oblong, cylindrical or triangular. They may differ greatly in size and weight depending on the amount of drug substance present and intended method of administration (1).
Hot Melt Extrusion Method:
To date HME has emerged as a novel processing technology in developing molecular dispersions of active pharmaceutical ingredients (APIs) into various polymer or/and lipid matrices which has led this technique to demonstrate time controlled, modified, extended, and targeted drug delivery. HME has now provided opportunity for use of materials in order to mask the bitter taste of active substances. Since the industrial application of the extrusion process back in the 1930's, HME has received considerable attention from both the pharmaceutical industry and academia in a range of applications for pharmaceutical dosage forms, such as tablets, capsules, films, and implants for drug delivery via oral, transdermal, and transmucosal routes (2) . This makes HME an excellent alternative to other conventionally available techniques such as roll spinning and spray drying. In addition to being a proven manufacturing process, HME meets the goal of the US Food and Drug Administration's (FDA) process analytical technology (PAT) scheme for designing, analyzing, and controlling the manufacturing process via quality control measurements during active extrusion process. In this research work extrusion technique is reviewed based on a holistic perspective of its various components, processing technologies, and the materials and novel formulation design and developments in its varied applications in oral drug delivery systems (3).
Process Technology of Hot-Melt Extrusion (HME)
Hot-melt extrusion technique was first invented for the manufacturing of lead pipes at the end of the eighteenth century. Since then, it has been used in the plastic, rubber, and food manufacturing industry to produce items ranging from pipes to sheets and bags. With the advent of high throughput screening, currently more than half of all plastic products including bags, sheets, and pipes are manufactured my HME and therefore various polymers have been used to melt and form different shapes for a variety of industrial and domestic applications (4) . The technology (HME) has proven to be a robust method of producing numerous drug delivery systems and therefore it has been found to be useful in the pharmaceutical industry as well. Extrusion is the process of pumping raw materials at elevated controlled temperature and pressure through a heated barrel into a product of uniform shape and density (5) . Breitenbach first introduced the development ofmelt extrusion process in pharmaceutical manufacturing operations; however, Follonier and his coworkers first examined the hot-melt technology to manufacture sustained release polymer-based pellets of various freely soluble drugs. HME involves the compaction and conversion of blends from a powder or a granular mix into a product of uniform shape (6) . During this process, polymers are melted and formed into products of different shapes and sizes such as plastic bags, sheets, and pipes by forcing polymeric components and active substances including any additives or plasticisers through an orifice ordie under controlled temperature, pressure, feeding rate, and screw speed.
However, the theoretical approach to understanding the melt extrusion process ( Figure 1 ) can be summarized by classifying the whole procedure of HME compaction into the following:
(1) Feeding of the extruder through a hopper, (2) Mixing, grinding, reducing the particle size, venting, and kneading,
(3) Flow through the die, and (4) Extrusion from the die and further downstream processing.
FIGURE-1 Schematic diagram of the HME process
The extruder generally consists of one or two rotating screws (either corotating or counter rotating) inside a stationary cylindrical barrel. The barrel is often manufactured in sections in order to shorten the residence time of molten materials. The sectioned parts of the barrel are then bolted or clamped together. An end-plate die is connected to the end of the barrel which is determined according to the shape of the extruded materials (7) .
Single-Screw and Twin-Screw Extruder
A single-screw extruder consists of one rotating screw positioned inside a stationary barrel at the most fundamental level. In the more advanced twin-screw systems, extrusion of materials is performed by either a corotating or counterrotating screw configuration. Irrespective of type and complexity of the function and process, the extruder must be capable of rotating the screw at a selected predetermined speed while compensating for the torque and shear generated from both the material being extruded and the screws being used. (8) . However, regardless of the size and type of the screw inside the stationary barrel a typical extrusion set up consists of a motor which acts as a drive unit, an extrusion barrel, a rotating screw, and an extrusion die. A central electronic control unit is connected to the extrusion unit in order to control the process parameters such as screw speed, temperature, and therefore pressure. This electronic control unit acts as a monitoring device as well (9) .The typical length diameter ratios (L/D) of screws positioned inside the stationary barrel are another important characteristic to consider whether the extrusion equipment is a single-screw or twinscrew extruder. The L/D of the screw either in a single-screw extruder or a twin-screw extruder typically ranges from 20 to 40: 1 (mm). In case of the application of pilot plant extruders the diameters of the screws significantly ranges from 18 to 30 mm. In pharmaceutical scale up, the production machines are much larger with diameters typically exceeding 50-60mm. In addition, the dimensions of a screw change over the length of the barrel. In the most advanced processing equipment for extrusion, the screws could be separated by clamps or be extended in proportion to the length of the barrel itself. A basic singlescrew extruder consists of three discrete zones: feed zone, compression, and a metering zone (10). Under the compression zone which is basically known as processing zone could be accompanied by few other steps such as mixing, kneading, and venting. The depth along with the pitch of the screw flights (both perpendicular and axial) differ within each zone, generating dissimilar pressures along the screw length (11) .
Figure 3: Screw geometry (extrusion)
Normally the pressure within the feed zone is very low in order to allow for consistent feeding from the hopper and gentle mixing of API, polymers, and other excipients and therefore the screw flight depth and pitch are kept larger than that of other zones. At this stage of the process the pressure within the extruder is very low which subsequently gets increased in the compression zone (12) . This process results in a gradual increase in pressure along the length of the compression zone, which effectively imparts a high degree of mixing and compression to the material (by decreasing the screw pitch and/or the flight depth). Moreover the major aim of the compression zone is not only to homogenize but also compress the extrudate to ensure the molten material reaches the final section of the barrel (metering zone) in a form appropriate for processing. Finally the final section which is known as the metering zone stabilizes the effervescent flow of the matrix and ensures the extruded product has a uniform thickness, shape, and size (13) . A constant and steady uniform screw flight depth and pitch helps to maintain continuous high pressure ensuring a uniform delivery rate of extrudates through the extrusion die and hence a uniform extruded product. In addition to the above-mentioned systems, downstream auxiliary equipment for cooling, cutting, and collecting the finished product is also typically employed. Mass flow feeders to accurately meter materials into the feed hopper pelletizers, spheronizer, roller/calendaring device in order to produce continuous films, and process analytical technology such as near infrared (NIR) and Raman, ultrasound, and DSC systems are also options. Throughout the whole process, the temperature in all zones is normally controlled by electrical heating bands and monitored by thermocouples. The singlescrew extrusion system is simple and offers lots of advantages but still does not acquire the mixing capability of a twin-screw machine and therefore is not the preferred approach for the production of most pharmaceutical formulations. Moreover, a twin-screw extruder offers much greater versatility (process manipulation and optimisation) in accommodating a wider range of pharmaceutical formulations making this setup much more constructive. The rotation of the screws inside the extruder barrel may either be corotating (same direction) or counter-rotating (opposite direction), both directions being equivalent from a processing perspective 2. Heat the sorbitan monolaurate to 60-70° C or till it forms a clear transparent solution into a stainless steel container.
Film coating material
3. Ingredients of step 1 were loaded into 3 ltr Rapid Mixer Granulator (RMG) and spray sorbitan mono laurate of step 3 slowly on this material with impellar at fast speed and chopper at slow speed then continue the mixing for 2 minutes after the complete spraying of sorbitan monolaurate with impellar at fast speed and chopper at slow speed.
4. Unload the material of step 4 with impeller at slow speed and check the weight of the material.
5. Calculate and weigh the actual quantity of material office step 5 required for the required for the batch.
6. Load about 25 % w/w of sifted copovidone of step 2, material of step 6 and about 25% w/w of sifted copovidone of step 2 into Rapid mixer granulator and mix for 5 minutes with impeller at slow speed.
7. Add the remaining quantity of sifted copovidone of step 2 to the material of step 7 and mix for 5 minutes with impeller at slow speed.
8. Unload the material of step 8 with impeller at slow speed.
9. Load the material of step 9 into a feeding Hopper of hot melt extruder and start the melt extrusion process. 19. Start the spray of coating suspension of step 18 after the product temperature reaches 35 ± 5°C, continue the coating till a coat weight build up of 2.08% w/w ± 0.50°C w/w per tablet was obtained. (14) . 
Different composition of ritonavir immediate release tablets
Weight Variation Test:
To study weight variation individual weights (WI) of 20 tablets from each formulation were noted using electronic balance. Their average weight (WA) was calculated. Percent weight variation was calculated as follows. Average weights of the tablets along with standard deviation values were calculated.
% weight variation = (WA-WI) x 100/ WA
As the total tablet weight was 655 mg, according to USP, out of twenty tablets ±5 % variation can be allowed for not more than two tablets.
Hardness Test:
10 tablets from each batch were selected and hardness was measured using tablet hardness tester to find the average tablet hardness or crushing strength. Hardness of 4 kg is considered suitable for handling the tablets.
Tablet Thickness:
Thickness and diameter of formulation trials were measured using a Digital vernier Caliper, Thickness Gauge. 10 tablets of each trial formulation were taken and measured individually at frequent intervals.
Friability (%):(15).
Friability was determined by taking 20 tablets. Tablets samples were weighed accurately and placed in Friabilator after the given specification 100 revolutions per min (4 min at 25 rpm). The tablets were weighed again and % friability was then calculated by:
%F = x 100
Where, % F = Friability of tablets in percent. W = Initial Wight of tablets. W0 = Final weight of tablets.
Comparison of Dissolution Profiles:
According to US FDA guidance for dissolution data equivalence, model independent approach is recommended. This involves the use of similarity (f2) and dissimilar factor (f1) which provides simple means to compare the dissolution data.
2.2.6. Similarity factor (f2): (16) .
The similarity factor f2 was defined as a logarithmic reciprocal square root transformation of the sum of squared error and is a measurement of the similarity in the percent (%) dissolution between the two curves. This was calculated to compare the test product and reference product with respect to the drug release or dissolution profiles (17) . It was calculated data according to the following equation:
f2 = 50 × log {[1+ (1/n) ∑t=1 n (Rt -Tt)2] -0.5 ×100}
Where, n = number of full time points Rt = the reference profile at the time point t Tt = the test profile at the same point t 2.2.7. Dissimilarity factor (f1): (18) .
It is also called as Difference factor. It describes the relative percentage error between two dissolution profiles. The percent error is zero when the test and reference profiles are identical and increases the proportionality with the dissimilarity between the two profiles. c. Analytical column: A stainless steel column 250 mm long, 4.6 mm internal diameter filled with Octyl silane chemically bonded to porous silica particles to 5µm diameter.
[Use Kromasil-100 C8 5µ (250 x 4.6mm)] or Equivalent.
RESULTS AND DISCUSSION
The present study was undertaken to formulate ritonavir IR tablets. The study involves preformulation studies of drug and excipients, formulation and processing development along with evaluation of tablets made with the optimized formulation. Finally film coated tablets were evaluated by in vitro methods 
Physical Characterization of Active Pharmaceutical Ingredient (API)
Solubility Studies
The solubility of ritonavir drug was studied in six different media. The API was found to be insoluble in water and also freely soluble in all the following medias. 
Post compression Studies
Ten tablets of each formulation (core and coated) are selected randomly and average weight was determined. Then individual tablet is weighed and compared with an average weight. The USP limit of % allowed variation of tablets above 400mg is ± 5%. The % weight variations of the formulations mentioned in above table are within the limit.
The values mentioned in above table for hardness test are within the limit and matching the innovator products Thickness of all the formulations was found in the range for core tablets 5.75 to 6.06 mm. and coated tablets for 6.09-6.67 Friability is the ability to withstand the abrasion during transporting. The friability limit according to USP is 0.5 to 1 %. The values mentioned for all the tests are within the limit. 
DISSOLUTION STUDIES
The dissolution was carried out for different formulation trials and also for the innovator. The various results that are obtained are tabulated below. 
Stability Data of formulation F5
Dissolution of trial F-5 tablets was comparable with marketed product. So tablets of this batch were kept for stability studies. The results of stability studies are shown in Formulation -5 Stability sample withdrawn 40 0 C/75%RH three months % drug releasing time profile comparing initial product with marketed product. 
CONCLUSION
The present work was carried out to formulate and evaluate Ritonavir immediate release tablets.The drug excipient compatibility studies were carried out by HPLC. Based on the results, it was confirmed that there is no interaction between drug and excipient at different conditions. Eight formulation trails of Ritonavir tablets were conducted using different polymers at different concentrations. Physical characterizations of marketed product API and solubility studies Flow properties of API were studied and it was confirmed that Ritonavir exhibits very poor flow properties Blends of all formulations were prepared and pre compression properties were studied. The results indicated that all the formulation blends exhibited good flow properties, Formulations were compressed by hot melt extrusion method and subjected to post compression studies. For core tablets and coated tablets respectively. The results were found to be within the limits.
In vitro drug release of all formulations was carried out in dissolution medium 900 ml purified water and in multimedia buffer by using USP type -II (paddle). Figure 6 showing dissolution profile of different formulations of ritonavir immediate release tablets. Among formulations developed by wet granulation method F5 shows highest % drug release (99 %) at 120 mins The optimized formulation was subjected to accelerated stability studies at a temperature and relative humidity of 40 C 75% 5% H for a period of three months. Tablets are evaluated for physical appearance, color, moisture content, assay, related substances and dissolution studies.
